16-22096897-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_173615.5(VWA3A):āc.53C>Gā(p.Thr18Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000336 in 1,549,548 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_173615.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VWA3A | NM_173615.5 | c.53C>G | p.Thr18Ser | missense_variant | 2/34 | ENST00000389398.10 | NP_775886.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VWA3A | ENST00000389398.10 | c.53C>G | p.Thr18Ser | missense_variant | 2/34 | 5 | NM_173615.5 | ENSP00000374049.5 |
Frequencies
GnomAD3 genomes AF: 0.0000397 AC: 6AN: 151322Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000511 AC: 8AN: 156416Hom.: 0 AF XY: 0.0000482 AC XY: 4AN XY: 82916
GnomAD4 exome AF: 0.0000329 AC: 46AN: 1398226Hom.: 0 Cov.: 30 AF XY: 0.0000304 AC XY: 21AN XY: 689692
GnomAD4 genome AF: 0.0000397 AC: 6AN: 151322Hom.: 0 Cov.: 31 AF XY: 0.0000406 AC XY: 3AN XY: 73824
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 07, 2022 | The c.53C>G (p.T18S) alteration is located in exon 2 (coding exon 2) of the VWA3A gene. This alteration results from a C to G substitution at nucleotide position 53, causing the threonine (T) at amino acid position 18 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at